申请人:Catalyst Therapeutics Pty Ltd
                            
                            
                                公开号:US20170114025A1
                            
                            
                                公开(公告)日:2017-04-27
                            
                            The present invention relates to methods for inhibiting necroptosis; screening methods for identifying compounds which inhibit necroptosis; and compounds for the inhibition of necroptosis, which may be useful in the treatment of conditions associated with deregulated necroptosis.